ARCHIVES

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 03 No. 48 | December 2, 1977

Download PDF Visit The Full Archive

Related Articles

HHS Carcinogen Guidelines Draft

June 13, 1980

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995